2025-2026 Request for Proposals
The Melanoma Research Alliance funds innovative research to advance melanoma prevention, detection, diagnosis, and treatment through multiple collaborative and translational science award mechanisms.
Funder: Melanoma Research Alliance
Due Dates (Anticipated): September 2026: LOI for Team Science & Academic-Industry Partnership Awards | September 2026: Young Investigator Eligibility Checklist & Biosketch | October 2026: RTFCCR-MRA Team Science LOI | November 2026: Full proposals for Young Investigator & Pilot Awards | January 2027: Invited full proposals for Team Science Awards | February 2027: RTFCCR-MRA Team Science invited full proposals
Funding Amounts: Team Science & Academic-Industry Partnership: up to $900,000 over 3 years | Young Investigator: up to $255,000 over 3 years | Pilot: up to $100,000 over 2 years | RTFCCR-MRA Team Science: up to $900,000 over 3 years
Summary: Supports high-impact translational and early clinical research to advance melanoma prevention, detection, diagnosis, and treatment, with multiple award mechanisms and special opportunities.
Key Information: All deadlines are anticipated/projected; check program page for official updates.
Description
The Melanoma Research Alliance (MRA) invites pre-clinical, translational, and early clinical research proposals aimed at achieving significant, near-term advancements in melanoma prevention, detection, diagnosis, and treatment. This program features multiple grant mechanisms, including Team Science Awards, Academic-Industry Partnership Awards, Young Investigator Awards, and Pilot Awards. Special opportunities are available for projects focused on acral and uveal melanoma, as well as for researchers based in the UK and Israel. Additionally, a joint RTFCCR-MRA Team Science Award supports research on melanoma early detection, diagnosis, and risk stratification. The RFP emphasizes high-impact, innovative research and encourages diverse applicants to drive progress and equity in melanoma research.
